The protozoan parasite Leishmania is a folate and pterin auxotroph. The main biopterin transporter (BT1) and pterin reductase (PTR1) have already been characterized in Leishmania. In this study we have succeeded in generating a BT1 and PTR1 null mutant in the same Leishmania tarentolae strain.
INTRODUCTION
The protozoan parasite Leishmania is responsible for a number of diseases with a wide range of clinical symptoms (1) . Chemotherapy is currently the only effective way to control the infection but the emergence of drug resistant organisms, particularly against the first line antimonial containing drugs, is complicating the treatment (2) . The discovery of new putative cellular targets is urgently required.
Leishmania differs from its mammalian host in that it cannot synthesize pterins from guanosine triphosphate (GTP) and differs from several microorganisms in that it cannot synthesize folates de novo.
Indeed, it lacks enzymes necessary for the conjugation of the three building blocks (pterin, para aminobenzoic acid, and glutamate) leading to folates (reviewed in (3) ). This pterin and folate auxotrophy of Leishmania has resulted in a pterin (BT1) (4, 5) and a multiplicity of folate (FT) transporters (6, 7) that allow the transport of folate and pterin derivatives. These derivatives can be reduced into active molecules by the parasite dihydrofolate reductase-thymidylate synthetase (DHFR-TS) and by a novel pterin reductase PTR1 (3, 8) . Leishmania does have an active folylpolyglutamate synthetase (FPGS) (9) permitting Leishmania to synthesize folylpolyglutamates that are essential for cellular retention (10) .
Reduced folates are one carbon donors in various metabolic reactions including the synthesis of thymidine. Pterins are essential growth factors of Leishmania (11) (12) (13) (14) and may play a number of other roles. Indeed, the almost completed L. major genome project has revealed homologues to aromatic amino acid hydroxylases and to products involved in the biosynthesis of the molybdopterin cofactor (3).
Finally, experimental evidence has been provided to link pterin levels with parasite metacyclogenesis (15) .
Leishmania cells often resist the antifolate drug methotrexate (MTX) by reducing the accumulation of the drug (16) (17) (18) . This can be achieved by gene deletion of some of the folate transporter FT genes (7) .
Since Leishmania is a folate auxotroph this gene deletion event needs to be compensated for, and we have found that in L. tarentolae strains, in which the main folate transporter is deleted, the biopterin transporter BT1, which can also transport some folates, is overexpressed (4) . The BT1 gene has been inactivated in a number of species (4, 5, 15) and while cells can grow in culture flasks, they are less virulent in animal models (19) demonstrating an important role for pterin transport in parasite biology.
The PTR1 gene has also been inactivated in a number of species and these PTR1 null mutants were more sensitive to MTX (20, 21) , had a decreased ability to reduce pterins and recently were shown in animal models to be more virulent, as low levels of reduced pterins induced metacyclogenesis (15) .
While pterins cannot serve for the de novo biosynthesis of folates, there are several interconnections between folate and pterin metabolism and several Leishmania species can grow in folate deficient medium provided that pterins are present (12, 14, 20) . It has been suggested that pterins could have a folate sparing effect, a phenomenon described 45 years ago in the related parasite Crithidia fasciculata (22) , although the mechanism by which this is achieved is not understood. In an attempt to further increase our understanding of pterin metabolism in Leishmania, we succeeded, somewhat surprisingly, in generating mutants in which both the main pterin transporter (BT1) and pterin reductase (PTR1) were disrupted by homologous recombination. Cells were viable, but some of their folate metabolism was changed. Since BT1 overexpression appears to compensate for mutations in the folate/MTX transporter in L. tarentolae MTX resistant mutants (4), we assumed that selection of MTX resistance in a BT1/PTR1 null mutant would leave folate transport intact. Selection of the BT1/PTR1 cells for MTX resistance led to unexpected results that will be presented here.
Enzymatic assays in crude extracts. FPGS activity of Leishmania cells was assayed using extracts prepared essentially as described previously (9) hours. 1A , 1B, lane 2). In this BT1 null mutant we introduced a NEO construct that would enable us to target the PTR1 gene (Fig. 1C) . Transfection of the BT1 null mutant with this construct led to G418 resistant parasites that indeed had integrated the NEO construct at the level of one PTR1 allele (not shown). By increasing the concentration of the selective drug G418 and subsequent cloning of the cell pool we were able to obtain by loss of heterozygocity a PTR1 null mutant in a BT1 null mutant background ( Fig. 1 ).
RESULTS

Generation of a
Indeed, while the intact PTR1 copy is part of an 2.3 kb XhoI-XhoI fragment (Fig. 1D , lane 1) this fragment increases to 3.2 kb in the null mutant and also hybridizes with a NEO probe (Fig. 1D , lane 2).
Due to the central role of pterins in Leishmania growth, we were surprised that we could obtain a L.
tarentolae BT1/PTR1 null mutant. Even more surprisingly, the genetic mutant had no measurable growth defect in the folate rich (15 µM ) medium SDM-79 ( Fig. 2A ) and had only a small growth defect in the low folate (20 nM ) medium M199 (Fig. 2B ). L. tarentolae cells disrupted in either PTR1
or BT1 were previously reported to be more sensitive to MTX while cells transfected with PTR1 and BT1 were found to be resistant to MTX (4, 20) . Indeed, the BT1 null mutant was four times more sensitive to MTX while the PTR1 null mutant was 50 times more sensitive than a wild-type cell ( Cells in M199 medium overexpressing PTR1 were also highly resistant to MTX (result not shown), but surprisingly BT1 overexpressing cells were not much more resistant to MTX compared to wild-type cells in the M199 medium (Fig. 3C ). We hypothesized that this discrepancy in BT1 mediated resistance between SDM-79 and M199 could be due to a difference in folate concentration. Indeed, when BT1
overexpressors were grown in M-199 medium, but with the addition of folic acid to concentrations found in SDM-79, the parasites were MTX resistant (Fig. 3C ).
Biological compensation following inactivation of the BT1 and PTR1 genes of Leishmania.
Based on the central role of pterins in Leishmania, it could be suggested that Leishmania cells would not thrive well in the absence of PTR1 and BT1, two proteins key in providing active pterins to the cell.
The BT1/PTR1 mutant had minimal growth defects ( Fig. 2) and cells have been propagated for over a year without problems. It is likely that several metabolic features are changed in this genetic mutant to compensate for the lack of BT1 and PTR1. As expected from a BT1 null mutant, there is no measurable biopterin uptake in the BT1/PTR1 null mutant (Fig. 4A) . In L. tarentolae cells in which folate uptake is greatly impaired we have observed an increased uptake of biopterin (4) and because there are several interconnections between folate and pterin metabolism we tested here whether folate uptake was modulated in the BT1/PTR1 null mutant. Surprisingly, we found that both folate and MTX uptake were slightly but repeatedly decreased in the BT1/PTR1 null mutant (Fig 4B,C) . Another aspect of folate metabolism that was recently studied in Leishmania cells concerned folate polyglutamylation, where folates are found mostly as pentaglutamates (9, 27) while MTX is found predominantly in the form of triglutamates in L. tarentolae (26) . We found that the glutamate chain lengths of both folate and most notably of MTX were increased significantly in the BT1/PTR1 null mutant compared to wild-type cells (Tables 1, 2 ). The HPLC analysis of folates for the BT1/PTR1 null mutant led to the observation of other radioactive peaks consistent with polyglutamates longer than Glu 6 (results not shown).
The alteration in folate transport and polyglutamylation in the TarII BT1/PTR1 null mutant compared to wild-type cells led us to test whether the copy number of genes coding for these activities was changed.
Several genes are possibly implicated in folate transport (6,7) and we used a probe recognizing several members of this gene family. A rearrangement of some folate transporter genes was observed in the BT1/PTR1 null mutant since a 2.5 kb PstI-PstI hybridizing fragment present in wild-type cells was absent in the genetic mutant (Fig. 5E, lane 1, 2) . The copy number of FPGS was similar in the wild-type and null mutant (Fig. 5F, lane 1, 2 ), but FPGS activity was significantly higher in the null mutant compared to wild-type cells (Fig 6) .
Selection of MTX resistant mutants in the BT1/PTR1 null mutants
Despite the fact that BT1/PTR1 null mutant cells were hypersensitive to MTX, we were interested in generating MTX resistant mutants in the hope of finding novel resistance genes. We succeeded in generating two highly MTX resistant mutants TarII MTX 50.2 and TarII MTX 500.3 (Fig. 3) . These highly resistant mutants had only a small growth defect compared to their parent genetic mutant (Fig. 2) .
We first tested whether folate/MTX uptake was impaired in these mutants that had no active BT1.
Against our expectations, these mutants exhibited a marked decrease in folate and MTX uptake ( (Fig. 5A, B) . Leishmania cells often resist drugs by gene amplification (28, 29) and this can often be detected by simple examination of ethidium bromide stained gels (30) . DNA amplification could easily be seen in the two independent mutants (Fig.   5C , lane 3 and 4). This amplified DNA codes for DHFR-TS (Fig. 5D ) the gene coding for the target of MTX but a locus usually not amplified in L. tarentolae selected for MTX resistance (31) . The transport defect of the MTX resistant mutant was due, particularly in mutant MTX 500.3 (Fig. 5E, lane 4) , to a gross rearrangement and gene deletion in the folate transporter gene family. The FPGS gene loci remained intact in the mutant (Fig. 5F ) but the distribution of MTX polyglutamates changed drastically (Table 2 ). The distribution of folylpolyglutamates was decreased slightly in the mutants compared to the parent strain with a decrease in Glu 6 and Glu 5 and an increase in Glu 4 and Glu 3 . The distribution of MTX polyglutamates in the mutant, however, was greatly perturbed with a switch from Glu 4 and Glu 5 in the
DISCUSSION
Pterins are important growth factors for Leishmania (11) (12) (13) (14) and reduced pterins have been shown to be involved in parasite differentiation (15) . We show here that cells without their main biopterin transporter and without their main pterin reductase are viable under the conditions tested (Fig. 2) . The pterin requirement of the BT1/PTR1 null mutant must be achieved by other means. For example, the catabolism of folic acid could lead to a pterin moiety for the cell. This catabolism could for example take place via a pteridine hydrolyzing enzyme described in many species of parasites related to Leishmania (32) . Alternatively, the genome of Leishmania seems to have several homologues of the folate/pterin transporters (7, 15) , and alteration in the expression of one of these members could lead to sufficient biopterin accumulation to allow the cells to survive. In fact, we have observed something different where some of the FT members were deleted (Fig. 5E ) and this or other defects led to a slightly decreased folate accumulation in the BT1/PTR1 null mutant (Fig. 4B) . The reason for transporter gene deletion in a BT1/PTR1 null mutant is unclear. We could speculate that a pterin containing compound could be transported by one of the FT gene family members and that the absence of its reduction (by PTR1) could lead to the build up of a compound detrimental to growth, thus explaining the deletion of some transporters. The deleted gene(s) do(es) not correspond to the main folate transporter, however (Fig.4B) . Further work will be required to try to test this speculative hypothesis, but in ongoing work,
we sometimes find it difficult to overexpress some of the FT members in a wild-type background ( (7) and D. Richard and MO, unpublished observations). It is possible also that in culture flasks there is sufficient biopterin that the biopterin requirement of the cell is met by diffusion, a phenomenon that has been suggested to occur in Leishmania (4, 5) . Since PTR1 is lacking in the same mutant, the reduction of pterins must also use another route. Since DHFR-TS cannot reduce pterins (33) 
it is likely that
Leishmania has a second enzyme capable of reducing pterins and evidence for this activity has been provided (21) . Moreover, in Trypanosoma cruzi, a kinetoplastid parasite distantly related to Leishmania, two pteridine reductase enzymes have been characterized (34). In addition to these defects, the BT1/PTR1 null mutant had increased FPGS activity (Fig. 6 ) which leads to an increase in the level of long chain folylpolyglutamates (Table 2 ). This increased polyglutamylation may lead to increased cellular retention of folates and thus compensate for the loss of some folate transporters resulting from gene rearrangements.
An important anticipated
but not yet demonstrated observation of this study is that gene disruption in a protozoan parasite can lead to an alteration in the expression of several other genes. This change in gene expression is possibly essential for enabling growth and this must always be taken into account, when looking at a phenotype following a gene disruption event. We were able to detect some of these changes (deletion of some putative transporters, increased FPGS activity) because they are involved in the same pathways as the gene under study, but it is possible that the expression of other gene products will also be altered. DNA arrays or proteomic studies (35-37) could pinpoint at the global level the genes/proteins whose expression are modified following gene inactivation.
While the BT1/PTR1 null mutant had no measurable growth defect it had a clear phenotype of hypersensitivity to MTX, which appears to consist of the additive contributions of the disruptions of PTR1 and BT1. PTR1 is an established MTX resistance determinant (25,38), while BT1 was isolated by functional cloning by selecting for MTX resistance (4). Amplification of BT1 has been observed in a number of Leishmania lines selected for MTX resistance ((39), our unpublished observations). In contrast to SDM-79 medium (Fig. 3A, B) , we found that BT1 overexpressors were not more resistant to MTX in M-199 medium (Fig. 3C ). This may explain why BT1 was not isolated in an independent functional cloning experiment using MTX selection in M-199 medium (40) . We had hypothesized that BT1 may mediate MTX resistance by selectively transporting folate but not MTX in cells in which the folate transporters were deleted (4). Since folate concentration differs greatly between SDM-79 and M-199 we tested whether the difference in resistance profiles mediated by BT1 is due to a difference in folate concentration between the media. This seems to be indeed the case (Fig 3C) . An increase in folate uptake mediated by BT1, measurable at high folate concentration (4), should confer MTX resistance, as folate should compete with MTX for targets.
We selected for two BT1/PTR1 null mutants highly resistant to MTX. We thought that since resistance to MTX mediated by reduced activity of the folate/MTX transporter in L. tarentolae is compensated by overexpressing BT1, cells deleted for BT1 would not resist MTX by reducing the activity of the folate transporter. This was not the case, however, where a markedly decreased uptake of both folate and MTX was noted in MTX resistant mutants (Fig. 4B, C) . These mutants have a small growth defect (Fig.2 ) but less than one could have expected when both biopterin and folate uptake are decreased simultaneously (Fig.4) . Since Leishmania is likely not able to synthesize folate and pterins de novo this suggests, at least in culture, that the small amount of pteridines taken up by these cells is sufficient to allow growth. Other mutations were also observed in these step by step selected resistant mutants, including amplification of the DHFR-TS gene (Fig.5) . Amplification of the DHFR-TS gene has been
tarentolae except when the PTR1 gene is deleted (31) . We found previously that both the strength of the resistance gene and the environment of the genomic locus determine the efficiency with which a locus will be amplified in Leishmania (31).
In several Leishmania species, folates are found mainly as pentaglutamates (9, 27) . In contrast, the glutamate chain length of MTX is much shorter, with few MTX polyglutamates in L. major and predominantly MTX triglutamates in L. tarentolae (26, 42) . The difference between the two species is not due to a difference in FPGS activity but could be due to an α-MTX hydrolase that is highly active in L. major but not in L. tarentolae (17, 26, 42) . Following the double inactivation of BT1 and PTR1, cells have increased FPGS activity (Fig.6 ). This was observed for folate (Table1) but it was even more spectacular for MTX where the most abundant species became MTX-Glu 5 . In the MTX resistant BT1/PTR1 null mutants we found that MTX existed almost exclusively in the monoglutamate form (Table 2) , while long chain folylpolyglutamates were still present. Reduced polyglutamylation of MTX is a well established resistance mechanism in mammalian cells (reviewed in (43)) and inactivation of a copy of FPGS in L. tarentolae can lead to MTX resistance (26) . The absence of MTX polyglutamates in these mutants is not due to a decrease in FPGS activity (Fig.6 ) and is not due to an increased activity of the MTX α-hydrolase (result not shown). A number of hypotheses can be advanced to try to explain why MTX is not polyglutamylated. The level of polyglutamylation in mammalian cells is controlled by the dual activities of FPGS and a γ-glutamyl hydrolase (GGH) (reviewed in (44)). One could invoke a mutant form of GGH that could preferentially depolyglutamylate MTX. Being less polyglutamylated, MTX would be expulsed more easily from cells. There is no evidence yet from the Leishmania genome project for the presence of a GGH. Other enzymatic activities such as ferritin and glutamate carboxypeptidase could also control the level of MTX polyglutamates (45) , although again, no evidence for these activities have been found in Leishmania. Alternatively, since the level of pteridine entering these MTX resistant cells is low (Fig. 4) , the little MTX that enters the cell may bind to the overexpressed DHFR-TS which could then prevent MTX polyglutamylation. However, in another MTX mutant, TarII MTX 1000.6, we observed decreased MTX polyglutamates but in this mutant the DHFR-TS gene was not amplified (26) . Further work will be required to pinpoint how exactly 
